BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25925418)

  • 1. The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.
    Yang J; AlTahan AM; Hu D; Wang Y; Cheng PH; Morton CL; Qu C; Nathwani AC; Shohet JM; Fotsis T; Koster J; Versteeg R; Okada H; Harris AL; Davidoff AM
    J Natl Cancer Inst; 2015 Jun; 107(6):djv080. PubMed ID: 25925418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer.
    Wu MJ; Chen CJ; Lin TY; Liu YY; Tseng LL; Cheng ML; Chuu CP; Tsai HK; Kuo WL; Kung HJ; Wang WC
    Theranostics; 2021; 11(16):7779-7796. PubMed ID: 34335964
    [No Abstract]   [Full Text] [Related]  

  • 4. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
    Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
    Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer.
    Tang DE; Dai Y; He JX; Lin LW; Leng QX; Geng XY; Fu DX; Jiang HW; Xu SH
    J Pathol; 2020 Oct; 252(2):101-113. PubMed ID: 32617978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
    Zhang L; Sokolowski N; Atmadibrata B; Liu T
    Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
    Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
    Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1.
    Tee AE; Ling D; Nelson C; Atmadibrata B; Dinger ME; Xu N; Mizukami T; Liu PY; Liu B; Cheung B; Pasquier E; Haber M; Norris MD; Suzuki T; Marshall GM; Liu T
    Oncotarget; 2014 Apr; 5(7):1793-804. PubMed ID: 24742640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
    Yang J; Milasta S; Hu D; AlTahan AM; Interiano RB; Zhou J; Davidson J; Low J; Lin W; Bao J; Goh P; Nathwani AC; Wang R; Wang Y; Ong SS; Boyd VA; Young B; Das S; Shelat A; Wu Y; Li Z; Zheng JJ; Mishra A; Cheng Y; Qu C; Peng J; Green DR; White S; Guy RK; Chen T; Davidoff AM
    Cancer Res; 2017 Sep; 77(17):4626-4638. PubMed ID: 28684529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
    Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
    FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone demethylase KDM4B interacts with MyoD to regulate myogenic differentiation in C2C12 myoblast cells.
    Choi JH; Song YJ; Lee H
    Biochem Biophys Res Commun; 2015 Jan; 456(4):872-8. PubMed ID: 25534856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
    Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
    Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T
    Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase.
    Berry WL; Kim TD; Janknecht R
    Int J Oncol; 2014 Apr; 44(4):1341-8. PubMed ID: 24481461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.
    Lin LL; Huang CC; Wu CL; Wu MT; Hsu WM; Chuang JH
    Lab Invest; 2016 Jul; 96(7):719-30. PubMed ID: 27183205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
    Liu T; Tee AE; Porro A; Smith SA; Dwarte T; Liu PY; Iraci N; Sekyere E; Haber M; Norris MD; Diolaiti D; Della Valle G; Perini G; Marshall GM
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18682-7. PubMed ID: 18003922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
    Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
    Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.
    Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ
    Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
    BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.
    Young LC; McDonald DW; Hendzel MJ
    J Biol Chem; 2013 Jul; 288(29):21376-21388. PubMed ID: 23744078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.